Literature DB >> 24126017

Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase.

Ryan J Holland1, Rika Paulisch, Zhao Cao, Larry K Keefer, Joseph E Saavedra, Sonia Donzelli.   

Abstract

We introduce a strategy for generating mixtures of nitric oxide (NO) and nitroxyl (HNO) at tunable rates in physiological media. The approach involves converting a spontaneously HNO/NO-generating ion to a caged (prodrug) form that is essentially stable in neutral media, but that can be activated for HNO/NO release by adding an enzyme capable of efficiently opening the cage to regenerate the ion. By judiciously choosing the enzyme, substrate, and reaction conditions, unwanted scavenging of the HNO and NO by the protein can be minimised and the catalytic efficiency of the enzyme can be maintained. We illustrate this approach with a proof-of-concept study wherein the prodrug is Gal-IPA/NO, a diazeniumdiolate of structure iPrHN-N(O)NOR, with R=β-d-galactosyl. Escherichia coli-derived β-d-galactosidase at concentrations of 1.9-15nM hydrolysed 56μM substrate with half-lives of 140-19min, respectively, producing the IPA/NO anion (iPrHN-N(O)NO(-), half-life ∼3min), which in turn spontaneously hydrolysed to mixtures of HNO with NO. Using saturating substrate concentrations furnished IPA/NO generation rates that were directly proportional to enzyme concentration. Consistent with these data, the enzyme/substrate combination applied to ventricular myocytes isolated from wild-type mouse hearts resulted not only in a significant positive inotropic effect, but also rescued the cells from the negative inotropy, hypercontractions, and occasional cell death seen with the enzyme alone. This mechanism represents an alternate approach for achieving controlled fluxes of NO/HNO to investigate their biological actions.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Diazeniumdiolate; Gal-IPA/NO; HNO; IPA/NO; NO; Nitroxyl; Prodrug; nitric oxide; nitroxyl; sodium 1-(isopropylamino)diazen-1-ium-1,2-diolate; β-Galactosidase

Mesh:

Substances:

Year:  2013        PMID: 24126017      PMCID: PMC3881966          DOI: 10.1016/j.niox.2013.10.003

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  26 in total

Review 1.  Donors of HNO.

Authors:  Katrina M Miranda; Herbert T Nagasawa; John P Toscano
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

2.  The shy Angeli and his elusive creature: the HNO route to vasodilation.

Authors:  Nazareno Paolocci; David A Wink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

3.  Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in Vivo.

Authors:  Katrina M Miranda; Tatsuo Katori; Claudia L Torres de Holding; Lynta Thomas; Lisa A Ridnour; William J McLendon; Stephanie M Cologna; Andrew S Dutton; Hunter C Champion; Daniele Mancardi; Carlo G Tocchetti; Joseph E Saavedra; Larry K Keefer; K N Houk; Jon M Fukuto; David A Kass; Nazareno Paolocci; David A Wink
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

4.  N-hydroxybenzenecarboximidic acid derivatives: a new class of nitroxyl-generating prodrugs.

Authors:  M J Lee; D W Shoeman; D J Goon; H T Nagasawa
Journal:  Nitric Oxide       Date:  2001-06       Impact factor: 4.427

5.  One-electron reduction of aqueous nitric oxide: a mechanistic revision.

Authors:  Sergei V Lymar; Vladimir Shafirovich; Gregory A Poskrebyshev
Journal:  Inorg Chem       Date:  2005-07-25       Impact factor: 5.165

6.  Hydrolysis of acyloxy nitroso compounds yields nitroxyl (HNO).

Authors:  Xin Sha; T Scott Isbell; Rakesh P Patel; Cynthia S Day; S Bruce King
Journal:  J Am Chem Soc       Date:  2006-08-02       Impact factor: 15.419

7.  Chemistry of the diazeniumdiolates. O- versus N-alkylation of the RNH[N(O)NO](-) ion.

Authors:  Joseph E Saavedra; D Scott Bohle; Kamilah N Smith; Clifford George; Jeffrey R Deschamps; Damon Parrish; Joseph Ivanic; Yan-Ni Wang; Michael L Citro; Larry K Keefer
Journal:  J Am Chem Soc       Date:  2004-10-13       Impact factor: 15.419

8.  Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase.

Authors:  M J Lee; H T Nagasawa; J A Elberling; E G DeMaster
Journal:  J Med Chem       Date:  1992-10-02       Impact factor: 7.446

Review 9.  Nitroxyl (HNO): the Cinderella of the nitric oxide story.

Authors:  Jennifer C Irvine; Rebecca H Ritchie; Joanne L Favaloro; Karen L Andrews; Robert E Widdop; Barbara K Kemp-Harper
Journal:  Trends Pharmacol Sci       Date:  2008-10-01       Impact factor: 14.819

Review 10.  Nitroglycerine and sodium trioxodinitrate: from the discovery to the preconditioning effect.

Authors:  Pasquale Pagliaro; Donatella Gattullo; Claudia Penna
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2013-10       Impact factor: 2.160

View more
  4 in total

1.  Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.

Authors:  Gaurav Bharadwaj; Patricia G Z Benini; Debashree Basudhar; Cyf N Ramos-Colon; Gail M Johnson; Marti M Larriva; Larry K Keefer; Daniela Andrei; Katrina M Miranda
Journal:  Nitric Oxide       Date:  2014-09-02       Impact factor: 4.427

Review 2.  Carriers for the tunable release of therapeutics: etymological classification and examples.

Authors:  Vuk Uskoković; Shreya Ghosh
Journal:  Expert Opin Drug Deliv       Date:  2016-06-27       Impact factor: 6.648

3.  Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.

Authors:  Cian M McCrudden; John W McBride; Joanne McCaffrey; Ahlam A Ali; Nicholas J Dunne; Vicky L Kett; Jonathan A Coulter; Tracy Robson; Helen O McCarthy
Journal:  Mol Ther Nucleic Acids       Date:  2016-12-31       Impact factor: 8.886

4.  Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer.

Authors:  Cian M McCrudden; John W McBride; Joanne McCaffrey; Emma M McErlean; Nicholas J Dunne; Vicky L Kett; Jonathan A Coulter; Tracy Robson; Helen O McCarthy
Journal:  Cancer Nanotechnol       Date:  2018-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.